Formula 1’s reaction to season disruption a lesson for Fifa World Cup May 10, 2026 Formula 1 is firmly back on track but the consecutive Bahrain and Saudi Arabian race cancellations, the result of events in the Middle East, have highlighted how quickly established sporting fixtures can face significant disruption. The cost of the decision to cancel both races, given the potential risk to safety of staff working in the [...]
Gordon Brown returns to government as Starmer shrugs off resignation calls May 9, 2026 Former Prime Minister Gordon Brown has returned to government in a new role as Sir Keir Starmer has scrambled to save his premiership amid discontent among Labour MPs. Brown will serve as the government’s special envoy for global finance. He will likely be tasked with sorting finance for defence ahead of the publication of the [...]
Janus Henderson Group plc Reports First Quarter 2026 Results May 8, 2026 Solid long-term investment performance, with 66%, 67%, and 68% of assets under management (“AUM”) outperforming relevant benchmarks on a three-, five-, and 10-year basis, respectively, as of March 31, 2026 AUM of US$480 billion as of March 31, 2026, an increase of 29% year over year First quarter 2026 net inflows of US$2.9 billion compared to breakeven net flows in fourth quarter 2025 First quarter 2026 diluted EPS of US$0.59 and adjusted diluted EPS of US$0.90
Bulb’s chances are bright under Magic Man Moreira May 8, 2026 REGULAR Hong Kong racegoers will need to wait until the finale at Sha Tin for the feature race on the card – the six-furlong Class Two Sai Wan Shan Handicap (10.45am). The contest promises to be a mouth-watering spectacle, featuring some of the best handicap sprinters in town up against a couple of potential future [...]
Reply Presents the Jury of the Second Edition of the AI Music Contest: This Year Again, Finalists Will Perform on the NOVA Stage of Kappa FuturFestival in Turin May 8, 2026 Agoria, Max Cooper, Fleur Shore, Tini Gessler, Ali Demirel, Albi Scotti, Oliver Bohl and Sarah Grimaldi join the jury of the second edition of the competition dedicated to the dialogue between artificial intelligence and live performance.
CYNREN Launches Next Generation Advisory Firm Serving Family Offices, Funds and Institutions May 8, 2026 Founded by former partners of KPMG and Citibank with decades of experience guiding businesses, funds and families
AngloGold Ashanti Q1 31 March 2026 Earnings Release and Dividend Declaration May 8, 2026 AngloGold Ashanti delivers record free cash flow* of $1.2bn and EBITDA*(4) of $2.3bn • Gold production(1)(2) +1% • Net cash*(4) of $868m • Q1 2026 interim dividend of $585m, or 116 cps • Proposed $2.0bn share repurchase programme announced
Telekom Srbija Secures U.S. EXIM Financing to Accelerate 5G Rollout May 8, 2026 Approval from the Export-Import Bank of the United States will support Serbia’s next-generation telecoms expansion and strengthen U.S.–Serbia technology and economic ties
Sports industry braced for media rights dip, PwC report warns May 8, 2026 Sport bosses have warned that media rights are set to fall in value and can no longer be relied upon to drive growth across the industry. PwC’s Global Sports Survey of more than 500 senior executives found that growth was expected in all streams in the next three to five years, except media rights. Even [...]
Prothena Reports First Quarter 2026 Financial Results and Business Highlights May 7, 2026 Net cash provided by operating and investing activities was $28.9 million for the first quarter of 2026; quarter-end cash and restricted cash position was $330.3 million Prothena updates projected full year 2026 net cash used in operating and investing actives to be $18 to $23 million (versus prior guidance $50 to $55 million) and expects to end the year with approximately $273 million (midpoint) in cash, cash equivalents and restricted cash Novo Nordisk obtained Fast Track designation from the U.S. FDA for coramitug (PRX004) for the treatment of ATTR amyloidosis with cardiomyopathy and paid Prothena a $50 million clinical milestone payment related to Phase 3 enrollment Roche presented several clinical updates supporting the potential of prasinezumab for the treatment of Parkinson’s disease at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026) Prothena has completed the Phase 1 study for PRX019. Prothena could potentially earn a $55 million clinical milestone payment if Bristol Myers Squibb decides to advance the program; BMS decision expected by year-end 2026 Prothena initiated a share repurchase program to be conducted in 2026 for up to $100 million if deemed appropriate